
Systematic review of management of gallbladder disease in patients undergoing minimally invasive bariatric surgery.
The introduction and subsequent widespread adaptation of minimally invasive approaches for bariatric surgery have not only changed the outcomes of bariatric surgery but also called into question the management of co-morbid surgical conditions, in particular gallbladder disease. The American Society for Metabolic and Bariatric Surgery Foregut Committee performed a systematic review of the published literature from 1995-2018 on management of gallbladder disease in patients undergoing bariatric surgery. The papers reviewed generated the following results. (1) Routine prophylactic cholecystectomy at the time of bariatric surgery is not recommended. (2) In symptomatic patients who are undergoing bariatric surgery, concomitant cholecystectomy is acceptable and safe. (3) Ursodeoxycholic acid may be considered for gallstone formation prophylaxis during the period of rapid weight loss. (4) Routine preoperative screening and postoperative surveillance ultrasound is not recommended in asymptomatic patients. In the era of minimally invasive surgery, the management of gallbladder disease in patients undergoing bariatric surgery continues to evolve.
Duke Scholars
Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Ursodeoxycholic Acid
- Surgery
- Obesity, Morbid
- Minimally Invasive Surgical Procedures
- Humans
- Gallbladder Diseases
- Cholagogues and Choleretics
- Bariatric Surgery
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
Citation

Published In
DOI
EISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Ursodeoxycholic Acid
- Surgery
- Obesity, Morbid
- Minimally Invasive Surgical Procedures
- Humans
- Gallbladder Diseases
- Cholagogues and Choleretics
- Bariatric Surgery
- 1117 Public Health and Health Services
- 1103 Clinical Sciences